Receptor 2-dependent activity of native major outer membrane protein proteosomes of Chlamydia trachomatis

Infection and Immunity

Volumn 81, Issue 1, 2013, Pages 303-310

  Massari, Paola ^a   Toussi, Deana N ^a   Tifrea, Delia F ^b   De la Maza, Luis M ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MAJOR OUTER MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; OUTER MEMBRANE PROTEIN; PORIN; PROTEASOME; TLR2 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 1;

ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE OVEREXPRESSION; GENITAL SYSTEM; IN VITRO STUDY; INTRACELLULAR SIGNALING; MICELLE; NONHUMAN; PRIORITY JOURNAL; CELL LINE; CELL STRAIN HEK293; CHLAMYDIASIS; HELA CELL; HUMAN; METABOLISM; MICROBIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BACTERIAL OUTER MEMBRANE PROTEINS; CELL LINE; CELL LINE, TUMOR; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; EPITHELIAL CELLS; HEK293 CELLS; HELA CELLS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MICELLES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PORINS; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2;

EID: 84871890561     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01062-12     Document Type: Article

References (58)

1. Medzhitov R, Janeway C, Jr. 2000. The Toll receptor family and microbial recognition. Trends Microbiol. 8:452-456.
2. Akira S, Takeda K, Kaisho T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-680.
3. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274:10689-10692.
4. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor5. Nature 410:1099-1103.
5. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S, Wagner H, Lipford GB. 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. U. S. A. 98:9237-9242.
6. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738.
7. Kang JY, Nan X, Jin MS, Youn SJ, Ryu YH, Mah S, Han SH, Lee H, Paik SG, Lee JO. 2009. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31:873-884.
8. Asong J, Wolfert MA, Maiti KK, Miller D, Boons GJ. 2009. Binding and cellular activation studies reveal that Toll-like receptor 2 can differentially recognize peptidoglycan from Gram-positive and Gram-negative bacteria. J. Biol. Chem. 284:8643-8653.
9. Massari P, Visintin A, Gunawardana J, Halmen KA, King CA, Golenbock DT, Wetzler LM. 2006. Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling. J. Immunol. 176:2373-2380.
10. Liu X, Wetzler LM, Nascimento LO, Massari P. 2010. Human airway epithelial cell responses to Neisseria lactamica and purified porin via Toll-like receptor 2-dependent signaling. Infect. Immun.78:5314-5323.
11. Biswas A, Banerjee P, Mukherjee G, Biswas T. 2007. Porin of Shigella dysenteriae activates mouse peritoneal macrophage through Toll-like receptors 2 and 6 to induce polarized type I response. Mol. Immunol. 44: 812-820.
12. Cervantes-Barragan L, Gil-Cruz C, Pastelin-Palacios R, Lang KS, Isibasi A, Ludewig B, Lopez-Macias C. 2009. TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella Typhi antigens. Eur. J. Immunol. 39:126-135.
13. Galdiero M, Galdiero M, Finamore E, Rossano F, Gambuzza M, Catania MR, Teti G, Midiri A, Mancuso G. 2004. Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages. Infect. Immun. 72:1204-1209.
14. Toussi DN, Liu X, Massari P. 2012. The FomA porin from Fusobacterium nucleatum is a Toll-like receptor 2 agonist with immune adjuvant activity. Clin. Vaccine Immunol. 19:1093-1101.
15. Centers for Disease Control and Prevention. 2009. Chlamydia screening among sexually active young female enrollees of health plans-United States, 2000-2007. MMWR Morb. Mortal. Wkly. Rep. 58:362-365.
16. Westrom LV. 1996. Chlamydia and its effect on reproduction. J. Br. Fer. Soc. 1:23-30.
17. Grayston JT, Wang S. 1975. New knowledge of chlamydiae and the diseases they cause. J. Infect. Dis. 132:87-105.
18. Schachter J, Dawson CR. 2002. Elimination of blinding trachoma. Curr. Opin. Infect. Dis. 15:491-495.
19. Kumar S, Hammerschlag MR. 2007. Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin. Infect. Dis. 44:568-576.
20. Jackson LA, Campbell LA, Schmidt RA, Kuo C, Cappuccio AL, Lee MJ, Grayston JT. 2000. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma. J. Infect. Dis. 181(Suppl 3):S447-S448.
21. Joyee AG, Yang X. 2008. Role of toll-like receptors in immune responses to chlamydial infections. Curr. Pharm. Des. 14:593-600.
22. Welter-Stahl L, Ojcius DM, Viala J, Girardin S, Liu W, Delarbre C, Philpott D, Kelly KA, Darville T. 2006. Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum. Cell. Microbiol. 8:1047-1057.
23. Chamaillard M, Girardin SE, Viala J, Philpott DJ. 2003. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell. Microbiol. 5:581-592.
24. Derbigny WA, Shobe LR, Kamran JC, Toomey KS, Ofner S. 2012. Identifying a role for Toll-like receptor 3 in the innate immune response to Chlamydia muridarum infection in murine oviduct epithelial cells. Infect. Immun. 80:254-265.
25. Frazer LC, Darville T, Chandra-Kuntal K, Andrews CW, Jr, Zurenski M, Mintus M, AbdelRahman YM, Belland RJ, Ingalls RR, O'Connell CM. 2012. Plasmid-cured Chlamydia caviae activates TLR2-dependent signaling and retains virulence in the guinea pig model of genital tract infection. PLoS One 7:e30747. doi:10.1371/journal.pone.0030747.
26. O'Connell CM, AbdelRahman YM, Green E, Darville HK, Saira K, Smith B, Darville T, Scurlock AM, Meyer CR, Belland RJ. 2011. Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum. Infect. Immun. 79:1044-1056.
27. Bas S, Neff L, Vuillet M, Spenato U, Seya T, Matsumoto M, Gabay C. 2008. The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipo-protein, the macrophage infectivity potentiator, through TLR2/TLR1/ TLR6 and CD14. J. Immunol. 180:1158-1168.
28. Ingalls RR, Rice PA, Qureshi N, Takayama K, Lin JS, Golenbock DT. 1995. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect. Immun. 63:3125-3130.
29. Heine H, Lien E. 2003. Toll-like receptors and their function in innate and adaptive immunity. Int. Arch. Allergy Immunol. 130:180-192.
30. Bulut Y, Faure E, Thomas L, Karahashi H, Michelsen KS, Equils O, Morrison SG, Morrison RP, Arditi M. 2002. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J. Immunol. 168: 1435-1440.
31. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H, Wagner H. 2001. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276:31332-31339.
32. Da Costa CU, Wantia N, Kirschning CJ, Busch DH, Rodriguez N, Wagner H, Miethke T. 2004. Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur. J. Immunol. 34:2874-2884.
33. Beckett EL, Phipps S, Starkey MR, Horvat JC, Beagley KW, Foster PS, Hansbro PM. 2012. TLR2, but not TLR4, is required for effective host defence against chlamydia respiratory tract infection in early life. PLoS One 7:e39460. doi:10.1371/journal.pone.0039460.
34. O'Connell CM, Ionova IA, Quayle AJ, Visintin A, Ingalls RR. 2006. Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions. Evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen. J. Biol. Chem. 281:1652-1659.
35. He X, Nair A, Mekasha S, Alroy J, O'Connell CM, Ingalls RR. 2011. Enhanced virulence of Chlamydia muridarum respiratory infections in the absence of TLR2 activation. PLoS One 6:e20846. doi:10.1371/ journal.pone.0020846.
36. McCoy AJ, Maurelli AT. 2005. Characterization of Chlamydia MurCDdl, a fusion protein exhibiting D-alanyl-D-alanine ligase activity involved in peptidoglycan synthesis and D-cycloserine sensitivity. Mol. Microbiol. 57:41-52.
37. Patin D, Bostock J, Chopra I, Mengin-Lecreulx D, Blanot D. 2012. Biochemical characterisation of the chlamydial MurF ligase, and possible sequence of the chlamydial peptidoglycan pentapeptide stem. Arch. Microbiol. 194:505-512.
38. Bavoil P, Ohlin A, Schachter J. 1984. Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis. Infect. Immun. 44:479-485.
39. Rodriguez-Maranon MJ, Bush RM, Peterson EM, Schirmer T, de la Maza LM. 2002. Prediction of the membrane-spanning beta-strands of the major outer membrane protein of Chlamydia. Sci. 11:1854-1861.
40. Sun G, Pal S, Sarcon AK, Kim S, Sugawara E, Nikaido H, Cocco MJ, Peterson EM, de la Maza LM. 2007. Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis. J. Bacteriol. 189:6222-6235.
41. Kawa DE, Schachter J, Stephens RS. 2004. Immune response to the Chlamydia trachomatis outer membrane protein PorB. Vaccine 22:4282-4286.
42. Kari L, Whitmire WM, Crane DD, Reveneau N, Carlson JH, Goheen MM, Peterson EM, Pal S, de la Maza LM, Caldwell HD. 2009. Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine. J. Immunol. 182:8063-8070.
43. Cheng C, Pal S, Bettahi I, Oxford KL, Barry PA, de la Maza LM. 2011. Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model. Vaccine 29:3456-3464.
44. Sabet SF, Simmons J, Caldwell HD. 1984. Enhancement of Chlamydia trachomatis infectious progeny by cultivation of HeLa 229 cells treated with DEAE-dextran and cycloheximide. J. Clin. Microbiol. 20:217-222.
45. Massari P, King CA, Macleod H, Wetzler LM. 2005. Improved purification of native meningococcal porin PorB and studies on its structure/ function. Protein Expr. Purif. 44:136-146.
46. Fichorova RN, Rheinwald JG, Anderson DJ. 1997. Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol. Reprod. 57:847-855.
47. Harvey HA, Post DM, Apicella MA. 2002. Immortalization of human urethral epithelial cells: a model for the study of the pathogenesis of and the inflammatory cytokine response to Neisseria gonorrhoeae infection. Infect. Immun. 70:5808-5815.
48. Yen TY, Pal S, de la Maza LM. 2005. Characterization of the disulfide bonds and free cysteine residues of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein. Biochemistry 44:6250-6256.
49. Roebuck KA, Carpenter LR, Lakshminarayanan V, Page SM, Moy JN, Thomas LL. 1999. Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J. Leukoc. Biol. 65:291-298.
50. Toussi DN, Carraway M, Wetzler LM, Lewis LA, Liu X, Massari P. 2012. The amino acid sequence of Neisseria lactamica PorB surface-exposed loops influences Toll-like receptor 2-dependent cell activation. Infect. Immun. 80:3417-3428.
51. Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls RR. 2002. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J. Immunol. 168:2424-2432.
52. Al-Mously N, Eley A. 2007. Interaction of Chlamydia trachomatis serovar E with male genital tract epithelium results in secretion of proinflammatory cytokines. J. Med. Microbiol. 56:1025-1032.
53. Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang YX, Anderson DJ, Fierer J, Stephens RS, Kagnoff MF. 1997. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Invest. 99:77-87.
54. Wyllie DH, Kiss-Toth E, Visintin A, Smith SC, Boussouf S, Segal DM, Duff GW, Dower SK. 2000. Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J. Immunol. 165:7125-7132.
55. Massari P, Gunawardana J, Liu X, Wetzler LM. 2010. Meningococcal porin PorB prevents cellular apoptosis in a toll-like receptor 2- and NF-kappaB-independent manner. Infect. Immun. 78:994-1003.
56. Fazeli A, Bruce C, Anumba DO. 2005. Characterization of Toll-like receptors in the female reproductive tract in humans. Hum. Reprod. 20: 1372-1378.
57. Mackern-Oberti JP, Maccioni M, Cuffini C, Gatti G, Rivero VE. 2006. Susceptibility of prostate epithelial cells to Chlamydia muridarum infection and their role in innate immunity by recruitment of intracellular Toll-like receptors 4 and 2 and MyD88 to the inclusion. Infect. Immun. 74:6973-6981.
58. Gribar SC, Richardson WM, Sodhi CP, Hackam DJ. 2008. No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol. Med. 14:645-659.